Ypsomed Holding AG
Health Care
Current price
Target price 00%
Ranks rating
76
Position in sub-industry
126 / 236
Position in country
274 / 449
Return on Assets, %
8.4
1.6
Net income margin, %
14.3
2.7
EBITDA margin, %
29.6
10.2
Debt to Equity, %
35.3
13.9
Intangible assets and goodwill, %
27.4
2.7
Revenue CAGR 3Y, %
8
11.3
Revenue Y, % chg
8.9
0
P/E
71.5
25.8
P/BV
9
1.5
P/S
10.1
2.8
EV/S
10.5
2.5
EV/EBITDA
33.8
9
Average Analyst recommendation
Buy
Buy
Average upside forecasts, %
9.3
36.5
Forward P/E
43.8
18.3
Dividend Yield, %
0.3
2
Forward Dividend Yield, %
0.9
0.2
Expected dividend per share
3.7
0
Payout Ratio, %
24.5
32.2
Dividend Ex Date
2023-07-03
Competitors
Ranks
-
Shenzhen New Industries Biomedical Engineering Co Ltd
00%
-
EssilorLuxottica SA
00%
-
Hoya Corp
00%
-
Alcon AG
00%
-
ConvaTec Group PLC
00%
-
Ypsomed Holding AG
00%
-
Coloplast A/S
00%
-
Align Technology Inc
00%
-
Cooper Companies Inc
00%
-
HLB Inc
00%
Ready-made portfolio of the best Russian stocks
- Created by artificial intelligence
- Verified by analysts
- Available even to beginners
Company information
Country
Switzerland
Sector
Health Care
Industry group
Health Care Equipment & Services
Industry
Health Care Equipment & Supplies
Sub-sector
Health Care
Capitalization (millions of $)
5701.1
Ticker
YPHDF.PK
ISIN
CH0019396990
IPO date
2004-09-22
Availability on Russian exchanges
No
Reporting for
2023-11-15
Date fact. publication of reports
2023-09-30
Company Description
Ypsomed Holding AG is a Switzerland-based holding company engaged in the manufacture of injection pens for pharmaceutical and biotech companies. The Company develops and manufactures injection systems for custom-made self-administration, and markets pen needles for the treatment of diabetes, growth disorders or infertility, as well as therapeutic areas. The Company operates two business segments: Injection Systems and Diabetes Care. In the Injection Systems segment, the Company's YDS Ypsomed Delivery Systems offer a range of ready-to-use injection systems for pharmaceutical and biotech companies to administer of drugs or to develop and manufacture them in line with customer requirements. The Diabetes Care segment markets products such as pen needles or insulin pump to diabetics, doctors and health insurance providers. The Company operates its production sites in Burgdorf, Solothurn, Grenchen and Tabor, and sales and distribution network across Europe.
A step towards better analytics
- find the best promotions through the Screener
- keep an eye on stock valuation
- download detailed reports
and much more after free registration
RegistrationMore convenient from your phone? Download: